About ADDAX Biosciences
ADDAX Biosciences is a company based in Turin (Italy) founded in 2017. ADDAX Biosciences offers products and services including GAF. ADDAX Biosciences operates in a competitive market with competitors including GlyTech, Echelon Biosciences, Iceni Glycoscience, GlycoSpot and TFChem, among others.
- Headquarter Turin, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
FT Partners
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADDAX Biosciences
ADDAX Biosciences offers a comprehensive portfolio of products and services, including GAF.
Safe, non-toxic solution for preserving tissue in medical diagnostics.
Funding Insights of ADDAX Biosciences
Investors in ADDAX Biosciences
ADDAX Biosciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include FT Partners, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Investment banking services focused on fintech are provided.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for ADDAX Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADDAX Biosciences
Investment portfolio details for ADDAX Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ADDAX Biosciences
Detailed financials for ADDAX Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Addax Biosciences Comparisons
Peer comparison for ADDAX Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ADDAX Biosciences
ADDAX Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GlyTech, Echelon Biosciences, Iceni Glycoscience, GlycoSpot and TFChem, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Human-type Asp-linked glycans are supplied for research applications.
|
|
| Locked | Locked | Locked |
Reagents and assays for lipid biology research are manufactured.
|
|
| Locked | Locked | Locked |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| Locked | Locked | Locked |
High-throughput enzyme screening solutions are developed and provided.
|
|
| Locked | Locked | Locked |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
Detailed competitors of ADDAX Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Addax Biosciences
Complete news archive for ADDAX Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADDAX Biosciences
ADDAX Biosciences was founded in 2017 and raised its 1st funding round 3 years after it was founded.
ADDAX Biosciences is headquartered in Turin, Italy. It is registered at Turin, Piedmont, Italy.
Gianni Bussolati is the current CEO of ADDAX Biosciences.
ADDAX Biosciences was founded in 2017 in Turin, Italy, within the biotechnology sector. A patented non-toxic fixative is developed as a substitute for formalin, enabling histological, immunohistochemical, and molecular analyses with reduced health risks. Operations focus on laboratory applications to enhance worker safety and patient outcomes. Collaborations with research institutions are maintained to expand technology uses across various fields.
ADDAX Biosciences's top competitors include GlyTech, Echelon Biosciences and Iceni Glycoscience.
ADDAX Biosciences offers GAF.
ADDAX Biosciences has 3 investors. Key investors include FT Partners, European Union, and EIC Fund.